Wei H, Zhou C, Lin D, Liu B, Li Y, Zhao X, Wei S, Gong B, Liu K, Gong X, Liu Y, Zhang G, Chen J, Zhang J, Jin J, Qiu S, Gu R, Wang Y, Mi Y, Wang J. Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia. Haematologica 2021;106(5):1491-1495; https://doi.org/10.3324/haematol.2020.267526.